| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2012 ( Subtotal = $0 ) |
| | 2012 | 2009 | ORDWAY RESEARCH INSTITUTE INC | 150 NEW SCOTLAND AVENUE | ALBANY | NY | 12208 | ALBANY | USA | P01AI060908 | CHOOSING DRUG DOSES FOR BIODEFENSE PATHOGENS | 000 | 5 | NIH | 11/18/2011 | $0 |
|
| Issue Date FY: 2011 ( Subtotal = $24,179 ) |
| | 2011 | 2011 | ORDWAY RESEARCH INSTITUTE INC | 150 NEW SCOTLAND AVENUE | ALBANY | NY | 12208-3425 | ALBANY | USA | R01NS062784 | Involvement of astrocytic two-pore domain K+ channels in ischemic pathology | 000 | 2 | NIH | 5/31/2011 | $407,313 |
| | 2011 | 2011 | ORDWAY RESEARCH INSTITUTE INC | 150 NEW SCOTLAND AVENUE | ALBANY | NY | 12208-3425 | ALBANY | USA | R01NS062784 | Involvement of astrocytic two-pore domain K+ channels in ischemic pathology | 002 | 2 | NIH | 8/29/2011 | -$383,134 |
| | 2011 | 2010 | ORDWAY RESEARCH INSTITUTE INC | 150 NEW SCOTLAND AVENUE | ALBANY | NY | 12208 | ALBANY | USA | R01AG028687 | SECRETORY PATTERNS OF SENESCENT TUMOR CELLS | 000 | 4 | NIH | 8/24/2011 | $0 |
| | 2011 | 2009 | ORDWAY RESEARCH INSTITUTE INC | 150 NEW SCOTLAND AVENUE | ALBANY | NY | 12208 | ALBANY | USA | P01AI060908 | CHOOSING DRUG DOSES FOR BIODEFENSE PATHOGENS | 000 | 5 | NIH | 6/30/2011 | $0 |
|
| Issue Date FY: 2010 ( Subtotal = $2,929,766 ) |
| | 2010 | 2010 | ORDWAY RESEARCH INSTITUTE INC | 150 NEW SCOTLAND AVENUE | ALBANY | NY | 12208-3425 | ALBANY | USA | R01AI090802 | Optimization of Neoglycoside Antibiotics for Nosocomial Pathogens and Select Agen | 000 | 1 | NIH | 5/18/2010 | $874,998 |
| | 2010 | 2010 | ORDWAY RESEARCH INSTITUTE INC | 150 NEW SCOTLAND AVENUE | ALBANY | NY | 12208-3425 | ALBANY | USA | R01AI079729 | RESISTANCE SUPPRESSION FOR INFLUENZA VIRUS WITH COMBINATION CHEMOTHERAPY | 000 | 3 | NIH | 6/21/2010 | $571,330 |
| | 2010 | 2010 | ORDWAY RESEARCH INSTITUTE INC | 150 NEW SCOTLAND AVENUE | ALBANY | NY | 12208-3425 | ALBANY | USA | R21ES015954 | ACTIVATING LIVER CARCINOGENS IN YEAST BY EXPRESSING CYP450 POLYMORPHISMS | 002 | 2 | NIH | 5/31/2010 | $484 |
| | 2010 | 2010 | ORDWAY RESEARCH INSTITUTE INC | 150 NEW SCOTLAND AVENUE | ALBANY | NY | 12208-3425 | ALBANY | USA | R01AG028687 | SECRETORY PATTERNS OF SENESCENT TUMOR CELLS | 000 | 4 | NIH | 8/19/2010 | $330,159 |
| | 2010 | 2010 | ORDWAY RESEARCH INSTITUTE INC | 150 NEW SCOTLAND AVENUE | ALBANY | NY | 12208-3425 | ALBANY | USA | R01AI079578 | RESISTANCE SUPPRESSION FOR P. AERUGINOSA USING NOVEL COMBINATION THERAPY MODELING | 000 | 3 | NIH | 7/27/2010 | $750,762 |
| | 2010 | 2010 | ORDWAY RESEARCH INSTITUTE INC | 150 NEW SCOTLAND AVENUE | ALBANY | NY | 12208-3425 | ALBANY | USA | R01NS062784 | Involvement of astrocytic two-pore domain K+ channels in ischemic pathology | 000 | 1 | NIH | 6/21/2010 | $384,125 |
| | 2010 | 2010 | ORDWAY RESEARCH INSTITUTE INC | 150 NEW SCOTLAND AVENUE | ALBANY | NY | 12208-3425 | ALBANY | USA | R21ES015954 | ACTIVATING LIVER CARCINOGENS IN YEAST BY EXPRESSING CYP450 POLYMORPHISMS | 001 | 2 | NIH | 5/21/2010 | $17,908 |
| | 2010 | 2008 | ORDWAY RESEARCH INSTITUTE INC | 150 NEW SCOTLAND AVENUE | ALBANY | NY | 12208 | ALBANY | USA | R21ES015954 | ACTIVATING LIVER CARCINOGENS IN YEAST BY EXPRESSING CYP450 POLYMORPHISMS | 000 | 2 | NIH | 5/18/2010 | $0 |
|
| Issue Date FY: 2009 ( Subtotal = $4,126,239 ) |
| | 2009 | 2009 | ORDWAY RESEARCH INSTITUTE INC | 150 NEW SCOTLAND AVENUE | ALBANY | NY | 12208-3425 | ALBANY | USA | R01CA111618 | PROTOCADHERIN-PC AND PROSTATE CANCER | 001 | 5 | NIH | 3/24/2009 | $27,534 |
| | 2009 | 2009 | ORDWAY RESEARCH INSTITUTE INC | 150 NEW SCOTLAND AVENUE | ALBANY | NY | 12208-3425 | ALBANY | USA | R01CA111618 | PROTOCADHERIN-PC AND PROSTATE CANCER | 000 | 5 | NIH | 2/9/2009 | $247,799 |
| | 2009 | 2009 | ORDWAY RESEARCH INSTITUTE INC | 150 NEW SCOTLAND AVENUE | ALBANY | NY | 12208-3425 | ALBANY | USA | P01AI060908 | CHOOSING DRUG DOSES FOR BIODEFENSE PATHOGENS | 000 | 5 | NIH | 7/23/2009 | $1,860,566 |
| | 2009 | 2009 | ORDWAY RESEARCH INSTITUTE INC | 150 NEW SCOTLAND AVENUE | ALBANY | NY | 12208-3425 | ALBANY | USA | R01CA112481 | STEM CELLS AND HEPATOCARCINOGENESIS | 000 | 5 | NIH | 4/16/2009 | $255,805 |
| | 2009 | 2009 | ORDWAY RESEARCH INSTITUTE INC | 150 NEW SCOTLAND AVENUE | ALBANY | NY | 12208-3425 | ALBANY | USA | R01AI079729 | RESISTANCE SUPPRESSION FOR INFLUENZA VIRUS WITH COMBINATION CHEMOTHERAPY | 000 | 2 | NIH | 7/20/2009 | $561,962 |
| | 2009 | 2009 | ORDWAY RESEARCH INSTITUTE INC | 150 NEW SCOTLAND AVENUE | ALBANY | NY | 12208-3425 | ALBANY | USA | R01AI079729 | RESISTANCE SUPPRESSION FOR INFLUENZA VIRUS WITH COMBINATION CHEMOTHERAPY | 001 | 2 | NIH | 9/21/2009 | $0 |
| | 2009 | 2009 | ORDWAY RESEARCH INSTITUTE INC | 150 NEW SCOTLAND AVENUE | ALBANY | NY | 12208-3425 | ALBANY | USA | R01AI079729 | RESISTANCE SUPPRESSION FOR INFLUENZA VIRUS WITH COMBINATION CHEMOTHERAPY | 001 | 2 | NIH | 9/21/2009 | $89,448 |
| | 2009 | 2009 | ORDWAY RESEARCH INSTITUTE INC | 150 NEW SCOTLAND AVENUE | ALBANY | NY | 12208-3425 | ALBANY | USA | R21ES015954 | ACTIVATING LIVER CARCINOGENS IN YEAST BY EXPRESSING CYP450 POLYMORPHISMS | 000 | 2 | NIH | 5/29/2009 | $17,242 |
| | 2009 | 2009 | ORDWAY RESEARCH INSTITUTE INC | 150 NEW SCOTLAND AVENUE | ALBANY | NY | 12208 | ALBANY | USA | R21ES015954 | ACTIVATING LIVER CARCINOGENS IN YEAST BY EXPRESSING CYP450 POLYMORPHISMS | 001 | 2 | NIH | 7/15/2009 | $0 |
| | 2009 | 2009 | ORDWAY RESEARCH INSTITUTE INC | 150 NEW SCOTLAND AVENUE | ALBANY | NY | 12208-3425 | ALBANY | USA | R21ES015954 | ACTIVATING LIVER CARCINOGENS IN YEAST BY EXPRESSING CYP450 POLYMORPHISMS | 002 | 2 | NIH | 9/15/2009 | $222,920 |
| | 2009 | 2009 | ORDWAY RESEARCH INSTITUTE INC | 150 NEW SCOTLAND AVENUE | ALBANY | NY | 12208-3425 | ALBANY | USA | R01AI079578 | RESISTANCE SUPPRESSION FOR P. AERUGINOSA USING NOVEL COMBINATION THERAPY MODELING | 000 | 2 | NIH | 8/11/2009 | $782,530 |
| | 2009 | 2009 | ORDWAY RESEARCH INSTITUTE INC | 150 NEW SCOTLAND AVENUE | ALBANY | NY | 12208-3425 | ALBANY | USA | R01AG028687 | SECRETORY PATTERNS OF SENESCENT TUMOR CELLS | 000 | 3 | NIH | 8/6/2009 | $333,494 |
| | 2009 | 2008 | ORDWAY RESEARCH INSTITUTE INC | 150 NEW SCOTLAND AVENUE | ALBANY | NY | 12208-3425 | ALBANY | USA | R01DK071076 | HIGH THROUGHPUT SCREENS FOR FATTY ACID UPTAKE INHIBITORS | 000 | 3 | NIH | 2/13/2009 | -$21,073 |
| | 2009 | 2008 | ORDWAY RESEARCH INSTITUTE INC | 150 NEW SCOTLAND AVENUE | ALBANY | NY | 12208-3425 | ALBANY | USA | R01DK071076 | HIGH THROUGHPUT SCREENS FOR FATTY ACID UPTAKE INHIBITORS | 000 | 3 | NIH | 2/13/2009 | -$251,988 |
|
| Issue Date FY: 2008 ( Subtotal = $4,707,368 ) |
| | 2008 | 2008 | ORDWAY RESEARCH INSTITUTE INC | 150 NEW SCOTLAND AVENUE | ALBANY | NY | 12208 | ALBANY | USA | R01AG028687 | SECRETORY PATTERNS OF SENESCENT TUMOR CELLS | 000 | 2 | NIH | 7/30/2008 | $333,494 |
| | 2008 | 2008 | ORDWAY RESEARCH INSTITUTE INC | 150 NEW SCOTLAND AVENUE | ALBANY | NY | 12208 | ALBANY | USA | R01AI079729 | RESISTANCE SUPPRESSION FOR INFLUENZA VIRUS WITH COMBINATION CHEMOTHERAPY | 000 | 1 | NIH | 6/17/2008 | $563,765 |
| | 2008 | 2008 | ORDWAY RESEARCH INSTITUTE INC | 150 NEW SCOTLAND AVENUE | ALBANY | NY | 12208 | ALBANY | USA | R01AI079578 | RESISTANCE SUPPRESSION FOR P. AERUGINOSA USING NOVEL COMBINATION THERAPY MODELING | 000 | 1 | NIH | 7/25/2008 | $787,916 |
| | 2008 | 2008 | ORDWAY RESEARCH INSTITUTE INC | 150 NEW SCOTLAND AVENUE | ALBANY | NY | 12208 | ALBANY | USA | P01AI060908 | CHOOSING DRUG DOSES FOR BIODEFENSE PATHOGENS | 000 | 4 | NIH | 6/24/2008 | $1,887,352 |
| | 2008 | 2008 | ORDWAY RESEARCH INSTITUTE INC | 150 NEW SCOTLAND AVENUE | ALBANY | NY | 12208 | ALBANY | USA | R01DK071076 | HIGH THROUGHPUT SCREENS FOR FATTY ACID UPTAKE INHIBITORS | 000 | 3 | NIH | 4/28/2008 | $40,009 |
| | 2008 | 2008 | ORDWAY RESEARCH INSTITUTE INC | 150 NEW SCOTLAND AVENUE | ALBANY | NY | 12208 | ALBANY | USA | R01DK071076 | HIGH THROUGHPUT SCREENS FOR FATTY ACID UPTAKE INHIBITORS | 000 | 3 | NIH | 4/28/2008 | $346,256 |
| | 2008 | 2008 | ORDWAY RESEARCH INSTITUTE INC | 150 NEW SCOTLAND AVENUE | ALBANY | NY | 12208 | ALBANY | USA | R21ES015954 | ACTIVATING LIVER CARCINOGENS IN YEAST BY EXPRESSING CYP450 POLYMORPHISMS | 000 | 2 | NIH | 5/29/2008 | $217,438 |
| | 2008 | 2008 | ORDWAY RESEARCH INSTITUTE INC | 150 NEW SCOTLAND AVENUE | ALBANY | NY | 12208 | ALBANY | USA | R21DK076068 | VASCULAR TARGETING OF OXIDATIVE STRESS | 000 | 1 | NIH | 2/27/2008 | $0 |
| | 2008 | 2008 | ORDWAY RESEARCH INSTITUTE INC | 150 NEW SCOTLAND AVENUE | ALBANY | NY | 12208 | ALBANY | USA | R01CA111618 | PROTOCADHERIN-PC AND PROSTATE CANCER | 000 | 4 | NIH | 3/11/2008 | $275,333 |
| | 2008 | 2008 | ORDWAY RESEARCH INSTITUTE INC | 150 NEW SCOTLAND AVENUE | ALBANY | NY | 12208 | ALBANY | USA | R01CA112481 | STEM CELLS AND HEPATOCARCINOGENESIS | 000 | 4 | NIH | 5/19/2008 | $255,805 |
|
| Issue Date FY: 2007 ( Subtotal = $3,510,914 ) (Continued on the next page) |
| | 2007 | 2007 | ORDWAY RESEARCH INSTITUTE INC | 150 NEW SCOTLAND AVENUE | ALBANY | NY | 12208 | ALBANY | USA | R01DK071076 | HIGH THROUGHPUT SCREENS FOR FATTY ACID UPTAKE INHIBITORS | 000 | 2 | NIH | 4/25/2007 | $353,323 |
| | 2007 | 2007 | ORDWAY RESEARCH INSTITUTE INC | 150 NEW SCOTLAND AVENUE | ALBANY | NY | 12208 | ALBANY | USA | R21ES015954 | ACTIVATING LIVER CARCINOGENS IN YEAST BY EXPRESSING CYP450 POLYMORPHISMS | 000 | 1 | NIH | 8/1/2007 | $266,250 |
| | 2007 | 2007 | ORDWAY RESEARCH INSTITUTE INC | 150 NEW SCOTLAND AVENUE | ALBANY | NY | 12208 | ALBANY | USA | P01AI060908 | CHOOSING DRUG DOSES FOR BIODEFENSE PATHOGENS | 000 | 3 | NIH | 6/20/2007 | $1,788,209 |
| | 2007 | 2007 | ORDWAY RESEARCH INSTITUTE INC | 150 NEW SCOTLAND AVENUE | ALBANY | NY | 12208 | ALBANY | USA | R01AG028687 | SECRETORY PATTERNS OF SENESCENT TUMOR CELLS | 000 | 1 | NIH | 9/21/2007 | $363,875 |
| | 2007 | 2007 | ORDWAY RESEARCH INSTITUTE INC | 150 NEW SCOTLAND AVENUE | ALBANY | NY | 12208 | ALBANY | USA | R01DK071076 | HIGH THROUGHPUT SCREENS FOR FATTY ACID UPTAKE INHIBITORS | 001 | 2 | NIH | 8/28/2007 | $30,619 |
| | 2007 | 2007 | ORDWAY RESEARCH INSTITUTE INC | 150 NEW SCOTLAND AVENUE | ALBANY | NY | 12208 | ALBANY | USA | R01CA112481 | STEM CELLS AND HEPATOCARCINOGENESIS | 000 | 3 | NIH | 6/1/2007 | $255,805 |
| | 2007 | 2007 | ORDWAY RESEARCH INSTITUTE INC | 150 NEW SCOTLAND AVENUE | ALBANY | NY | 12208 | ALBANY | USA | R21CA125064 | ACTIVATING LIVER CARCINOGENS IN YEAST BY EXPRESSING CYP450 POLYMORPHISMS | 000 | 1 | NIH | 9/14/2007 | $177,500 |
|
